XML 69 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue - Gilead Sciences Inc (Details) - USD ($)
$ in Thousands
12 Months Ended
Oct. 14, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Collaboration and Other Agreements [Line Items]        
Revenues   $ 151,941 $ 77,447 $ 104,883
Gilead | 2022 Gilead Collaboration And License Agreement        
Collaboration and Other Agreements [Line Items]        
Target nomination, option fees and milestone $ 1,700,000      
Non-refundable upfront payment $ 60,000      
Revenues   200    
Deferred revenue   59,800    
Deferred revenue, current   1,800    
Deferred revenue, noncurrent   $ 58,000